NCT06646042View on ClinicalTrials.gov

A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 28, 2024

Primary Completion Date

January 17, 2025

Study Completion Date

January 17, 2025

Conditions
Healthy
Interventions
DRUG

ibuzatrelvir

2x 300 mg tablet

DRUG

carbamazepine ER

100 mg BID (Day 1-3) 200 mg BID (Day 4-7) 300 mg BID (Day 8-15)

Trial Locations (1)

06511

Pfizer Clinical Research Unit - New Haven, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY